Ran Meng Selected Research

Glucose Intolerance

1/2016	Silymarin alleviates hepatic oxidative stress and protects against metabolic disorders in high-fat diet-fed mice.
1/2013	Erythropoietin inhibits gluconeogenesis and inflammation in the liver and improves glucose intolerance in high-fat diet-fed mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ran Meng Research Topics

Disease

25	Stroke (Strokes) 01/2024 - 05/2006
22	Neoplasms (Cancer) 12/2023 - 01/2011
12	Thrombosis (Thrombus) 01/2023 - 12/2018
10	Insulin Resistance 08/2023 - 01/2010
10	Pathologic Constriction (Stenosis) 07/2023 - 01/2019
10	Ischemic Stroke 12/2022 - 06/2011
9	Inflammation (Inflammations) 01/2022 - 01/2010
7	Infarction (Infarctions) 08/2019 - 06/2011
7	Acute Promyelocytic Leukemia 09/2014 - 11/2003
6	Hemorrhage 01/2024 - 09/2018
6	Venous Thrombosis (Deep-Vein Thrombosis) 01/2023 - 01/2018
6	Ischemia 12/2021 - 05/2009
6	Cerebral Hemorrhage 10/2021 - 05/2009
5	Headache (Headaches) 07/2023 - 03/2019
5	Obesity 01/2021 - 08/2015
5	Leukemia 01/2019 - 11/2003
5	Breast Neoplasms (Breast Cancer) 01/2019 - 04/2013
4	Vascular Diseases (Vascular Disease) 01/2024 - 08/2018
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 01/2011
4	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2022
4	Thrombophilia 11/2022 - 02/2021
4	Brain Ischemia (Cerebral Ischemia) 10/2022 - 07/2015
4	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2011
4	Body Weight (Weight, Body) 01/2021 - 01/2013
4	Cerebral Infarction 01/2020 - 01/2006
3	Hypertension (High Blood Pressure) 05/2024 - 08/2015
3	Glioma (Gliomas) 12/2023 - 07/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 08/2023 - 01/2011
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2023 - 10/2018
3	Infections 01/2022 - 02/2012
3	Sepsis (Septicemia) 01/2021 - 12/2018
3	Hypothermia 01/2019 - 09/2017
3	Intracranial Sinus Thrombosis (Sinus Thrombosis) 10/2018 - 05/2013
3	Carcinoma (Carcinomatosis) 08/2013 - 01/2011
2	Diabetes Mellitus 05/2024 - 08/2023
2	Coronary Disease (Coronary Heart Disease) 05/2024 - 12/2021
2	Neuroinflammatory Diseases 03/2024 - 01/2023
2	Peripheral Arterial Disease 01/2024 - 12/2021
2	COVID-19 10/2023 - 01/2022
2	Brain Edema (Cerebral Edema) 07/2023 - 01/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 05/2023 - 06/2013
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2022 - 12/2021
2	Hyperhomocysteinemia 02/2022 - 11/2021
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2017
2	Hypoxia (Hypoxemia) 12/2021 - 08/2013
2	Edema (Dropsy) 01/2021 - 01/2020
2	Cognitive Dysfunction 01/2021 - 01/2019
2	Virus Diseases (Viral Diseases) 01/2021 - 01/2019
2	Bacterial Infections (Bacterial Infection) 01/2021 - 01/2019
2	Heart Failure 12/2020 - 07/2015
2	Liver Diseases (Liver Disease) 03/2019 - 01/2016
2	Reperfusion Injury 08/2018 - 02/2013
2	Necrosis 08/2017 - 12/2004

Drug/Important Bio-Agent (IBA)

16	Biomarkers (Surrogate Marker)IBA 07/2023 - 01/2006
11	Arsenic Trioxide (Trisenox)FDA Link 09/2014 - 11/2003
9	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2011
9	Glucose (Dextrose)FDA LinkGeneric 08/2023 - 01/2010
7	Oxygen (Dioxygen)IBA 01/2023 - 02/2013
7	salicylhydroxamic acid (SHAM)IBA 12/2022 - 07/2015
6	tetraiodothyroacetic acid (TA(4))IBA 05/2023 - 01/2011
5	Insulin (Novolin)FDA Link 01/2022 - 01/2010
5	Erythropoietin FDA Link 08/2019 - 01/2013
5	IntegrinsIBA 08/2013 - 01/2011
5	Aligeron (AS 2)IBA 01/2010 - 11/2003
4	BatroxobinIBA 10/2022 - 10/2018
4	fibrin fragment D (D-dimer)IBA 01/2021 - 05/2009
4	Fibrinogen (Factor I)FDA Link 01/2021 - 06/2011
4	SilymarinIBA 01/2021 - 01/2016
4	Estrogen ReceptorsIBA 07/2017 - 01/2011
4	Messenger RNA (mRNA)IBA 08/2016 - 02/2015
4	Thyroid HormonesIBA 08/2013 - 01/2011
3	Triglycerides (Triacylglycerol)IBA 11/2023 - 02/2022
3	Indicators and Reagents (Reagents)IBA 08/2023 - 01/2019
3	Mannitol (Osmitrol)FDA LinkGeneric 07/2023 - 09/2014
3	Peptides (Polypeptides)IBA 01/2023 - 01/2022
3	MicroRNAs (MicroRNA)IBA 11/2022 - 01/2018
3	Blood Glucose (Blood Sugar)IBA 02/2022 - 01/2013
3	Phosphotransferases (Kinase)IBA 10/2021 - 08/2017
3	LipopolysaccharidesIBA 01/2021 - 12/2018
3	LipidsIBA 03/2019 - 01/2017
3	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2018 - 01/2006
2	Warfarin (Coumadin)FDA LinkGeneric 04/2022 - 05/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2022 - 12/2021
2	AlbuminsIBA 01/2022 - 07/2021
2	CytokinesIBA 12/2021 - 01/2019
2	Oral ContraceptivesIBA 11/2021 - 02/2012
2	CalciumIBA 10/2021 - 10/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021 - 01/2021
2	HMGB1 Protein (HMG1)IBA 01/2021 - 01/2019
2	Neuroprotective AgentsIBA 08/2019 - 05/2013
2	dihydrocapsaicinIBA 01/2019 - 09/2017
2	CateninsIBA 01/2019 - 11/2015
2	ORALIT (ORS)IBA 01/2019 - 01/2019

Therapy/Procedure

24	Therapeutics 01/2024 - 11/2003
6	Stents 07/2023 - 12/2018
5	Intravenous Infusions 10/2018 - 11/2003
3	Ligation 03/2024 - 12/2018
2	Punctures 01/2021 - 12/2018
2	Induced Hypothermia 01/2019 - 09/2017
2	Thrombectomy 07/2018 - 05/2013